FDA advisers back Moderna's COVID-19 vaccine for teens and older kids
CBSN
A government advisory panel Tuesday endorsed a second brand of COVID-19 vaccine for school-age children and teens.
The Food and Drug Administration's outside experts voted unanimously that Moderna's vaccine is safe and effective enough to give kids ages 6 to 17. If the FDA agrees, it would become the second option for those children, joining Pfizer's vaccine.
The same FDA expert panel will meet Wednesday to consider tot-sized shots from Moderna and Pfizer for the littlest kids, those under 5.

Washington — President Trump said early Monday that he is postponing airstrikes on Iran's power plants after "very good and productive conversations" over the last two days about reopening the Strait of Hormuz. However, Iran's foreign ministry denied any such talks. Claire Day contributed to this report. In:












